Silence Therapeutics Operating Margin Growth & History (SLN)
Silence Therapeutics's operating margin was −16,292.84% for fiscal 2025.
View full Silence Therapeutics company overviewSilence Therapeutics annual operating margin history
2022
2023
2024
2025
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −16,292.84% | −16146.47 pp |
| 2024 | 2024-12-31 | −146.38% | +57.09 pp |
| 2023 | 2023-12-31 | −203.47% | +78.41 pp |
| 2022 | 2022-12-31 | −281.87% | — |
Silence Therapeutics quarterly operating margin
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −3,729.15% | +16277.19 pp |
| Q4 2025 | 2025-12-31 | −36,650.00% | −36632.80 pp |
| Q3 2025 | 2025-09-30 | −16,505.66% | −14503.19 pp |
| Q2 2025 | 2025-06-30 | −10,697.77% | −7604.12 pp |
| Q1 2025 | 2025-03-31 | −20,006.34% | −19970.79 pp |
| Q4 2024 | 2024-12-31 | −17.20% | — |
| Q3 2024 | 2024-09-30 | −2,002.47% | — |
| Q2 2024 | 2024-06-30 | −3,093.65% | — |
| Q1 2024 | 2024-03-31 | −35.55% | — |
Silence Therapeutics operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Silence Therapeutics's operating margin decreased from −281.87% to −16,292.84%, a change of −16010.97 percentage points. The latest reported quarter, Q1 2026, shows −3,729.15%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Silence Therapeutics source filings ↗